AtriCure Net Receivables from 2010 to 2026
| ATRC Stock | USD 36.80 1.27 3.34% |
Net Receivables | First Reported 2004-12-31 | Previous Quarter 66 M | Current Value 63 M | Quarterly Volatility 16.6 M |
Check AtriCure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AtriCure's main balance sheet or income statement drivers, such as Interest Expense of 7.7 M, Total Revenue of 561.9 M or Gross Profit of 419.6 M, as well as many indicators such as Price To Sales Ratio of 3.37, Dividend Yield of 0.0 or PTB Ratio of 3.71. AtriCure financial statements analysis is a perfect complement when working with AtriCure Valuation or Volatility modules.
AtriCure | Net Receivables | Build AI portfolio with AtriCure Stock |
Analyzing AtriCure's Net Receivables over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Receivables has evolved provides context for assessing AtriCure's current valuation and future prospects.
Latest AtriCure's Net Receivables Growth Pattern
Below is the plot of the Net Receivables of AtriCure over the last few years. It is AtriCure's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AtriCure's overall financial position and show how it may be relating to other accounts over time.
| Net Receivables | 10 Years Trend |
|
Net Receivables |
| Timeline |
AtriCure Net Receivables Regression Statistics
| Arithmetic Mean | 30,880,512 | |
| Geometric Mean | 23,940,271 | |
| Coefficient Of Variation | 68.84 | |
| Mean Deviation | 17,120,014 | |
| Median | 23,146,000 | |
| Standard Deviation | 21,258,069 | |
| Sample Variance | 451.9T | |
| Range | 69.3M | |
| R-Value | 0.94 | |
| Mean Square Error | 52.7T | |
| R-Squared | 0.89 | |
| Slope | 3,972,734 | |
| Total Sum of Squares | 7230.5T |
AtriCure Net Receivables History
About AtriCure Financial Statements
AtriCure stakeholders use historical fundamental indicators, such as AtriCure's Net Receivables, to determine how well the company is positioned to perform in the future. Although AtriCure investors may analyze each financial statement separately, they are all interrelated. For example, changes in AtriCure's assets and liabilities are reflected in the revenues and expenses on AtriCure's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AtriCure. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Receivables | 69.4 M | 72.9 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:Check out the analysis of AtriCure Correlation against competitors. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Will Health Care Equipment & Supplies sector continue expanding? Could AtriCure diversify its offerings? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every AtriCure data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.59) | Revenue Per Share | Quarterly Revenue Growth 0.158 | Return On Assets | Return On Equity |
Understanding AtriCure requires distinguishing between market price and book value, where the latter reflects AtriCure's accounting equity. The concept of intrinsic value - what AtriCure's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push AtriCure's price substantially above or below its fundamental value.
Understanding that AtriCure's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AtriCure represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, AtriCure's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.